Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem CellsBone Marrow TransplantationTransplantation ConditioningStem Cell TransplantationLiver TransplantationGraft vs Host DiseaseStem CellsPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntigens, CD34Hematologic NeoplasmsTreatment OutcomeKidney TransplantationHematopoietic Stem Cell MobilizationMelphalanTransplantationGraft SurvivalHematopoiesisCombined Modality TherapyCell TransplantationStem Cell NicheLymphoma, Non-HodgkinHeart TransplantationTissue DonorsHistocompatibility TestingImmunosuppressive AgentsBone MarrowSalvage TherapyBone Marrow PurgingLung TransplantationTransplantation ChimeraAdult Stem CellsCell DifferentiationCarmustineRecurrenceRetrospective StudiesLeukapheresisGranulocyte Colony-Stimulating FactorColony-Forming Units AssayLeukemiaWhole-Body IrradiationCyclophosphamideBone Marrow CellsAntineoplastic Combined Chemotherapy ProtocolsRemission InductionCells, CulturedHepatic Veno-Occlusive DiseaseFollow-Up StudiesFlow CytometryDisease-Free SurvivalOrgan TransplantationPancytopeniaBusulfanSurvival AnalysisEtoposideMice, Inbred C57BLHodgkin DiseaseBlood Transfusion, AutologousCell LineageGraft RejectionImmunocompromised HostTime FactorsSurvival RateCytarabinePancreas TransplantationIslets of Langerhans TransplantationTransplantation ImmunologyGraft vs Tumor EffectMyeloablative AgonistsHLA AntigensAnemia, AplasticFetal BloodThalidomideKanamycin KinaseMesenchymal Stem Cell TransplantationCell SeparationTransplantation, IsogeneicBlood Component RemovalCord Blood Stem Cell TransplantationVincristineFeasibility StudiesCell ProliferationPrognosisNeoplasm, ResidualGenetic TherapyLymphomaStromal CellsLiving DonorsTransplantation, HeterotopicIdarubicinPlant StemsPrednisoneLeukemia, Myeloid, AcuteCell CountAntineoplastic Agents, AlkylatingMyelodysplastic SyndromesDexamethasone